Definitions

from Wiktionary, Creative Commons Attribution/Share-Alike License.

  • noun biochemistry Any of a class of proteins that bind to ciclosporin

Etymologies

Sorry, no etymologies found.

Examples

  • a potential first-in-class antiviral agent currently in Phase IIb development for the treatment of hepatitis C. Debio 025 is the first in a new class of drugs called cyclophilin inhibitors which could become part of the future standard of care for the disease.

    WebWire | Recent Headlines

  • A NMR structure determination of the cyclophilin A-cyclosporin A complex was pursued as a joint project with two former graduate students,

    Kurt Wüthrich - Autobiography

  • They had a homozygous start-codon mutation in the peptidyl-prolyl isomerase B gene (PPIB), which results in a lack of cyclophilin

    Medlogs - Recent stories

  • Debio 025 (alisporivir), a selective, first-in-class cyclophilin

    FinanzNachrichten.de: Aktuelle Nachrichten

  • They had a homozygous start-codon mutation in the peptidyl-prolyl isomerase B gene (PPIB), which results in a lack of cyclophilin

    Medlogs - Recent stories

  • They had a homozygous start-codon mutation in the peptidyl-prolyl isomerase B gene (PPIB), which results in a lack of cyclophilin

    Medlogs - Recent stories

  • Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, today announced the signature of an exclusive licence agreement with Novartis for the development, manufacture and commercialisation of Debio 025 (alisporivir), a selective, first-in-class cyclophilin (Cyp) inhibitor with a potent anti-hepatitis C virus (HCV) effect.

    THE MEDICAL NEWS

  • Lausanne (ots) - Debiopharm Group [TM] (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, today announced the signature of an exclusive licence agreement with Novartis for the development, manufacture and commercialisation of Debio 025 (alisporivir), a selective, first-in-class cyclophilin (Cyp) inhibitor with a potent anti-hepatitis C virus

    Presseportal

  • They had a homozygous start-codon mutation in the peptidyl-prolyl isomerase B gene (PPIB), which results in a lack of cyclophilin

    Medlogs - Recent stories

  • Research shows that cyclophilin inhibitors have neuroprotective effects which open broad therapeutic areas of completely unmet medical need to Isotechnika such as USPTO issues two new patents for EKR Therapeutics 'RTU Cardene I.V. Premixed Injection

    THE MEDICAL NEWS

Comments

New comments are temporarily disabled while we update our database.